Dimensions of the Mysticism Scale: Confirming the Three‐Factor Structure in the United States and Iran
By Ralph W. Hood, Jr., N. Ghorbani, P. J. Watson, Ahad Framarz Ghramaleki, M. Bing, H. K. Davison, R. J. Morris, W. Williamson. 2001
217 citations recorded by the source corpus.
Subfields: Applied Psychology, Health, Social Psychology
View Paper: https://www.semanticscholar.org/paper/c0e56c714b26dba814cb018c0aaee9cd6fba8c27
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Psychology
- R. Hood
- Jonathan Haidt
- Roland R. Griffiths
- Margaret L. Kern
- David R. Vago
- Matthew W. Johnson
- Peter C. Hill
In Health
- Roland R. Griffiths
- Matthew W. Johnson
- R. Hood
- W. Paul Williamson
- M. Sadiq
- Jonathan Haidt
- Margaret L. Kern
- Peter C. Hill
In Social Psychology
- David B. Yaden
- Andrew B. Newberg
- David R. Vago
- R. Hood
- Roland R. Griffiths
- Matthew W. Johnson
- Jonathan Haidt
- Johannes C. Eichstaedt
Citations in the corpus
- Empirically based psychology of Islam: summary and critique of the literature (2011, unknown): “…2009b; Anthony, Hermans, & Sterkens, 2007; Burazeri, Goda, Roshi, & Kark, 2008; Fox & Thomas, 2008; Ghorbani, Watson, Krauss, Bing, & Davison, 2004; Hood et al., 2001; Leach, Piedmont, & Monterio, 2001; Loewenthal, MacLeod, & Cinnirella, 2002; Mussap, 2009; Piedmont & Leach, 2002; Stompe et al.,…”
- Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness (2011, methodology): “The Mysticism Scale was originally developed to assess mystical experiences across the lifetime and has been validated in several studies, including crossculturally (Hood, 1975, 2003; Hood et al., 2001).”
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015, unknown): “Additional measures of persisting psychological effects obtained but not discussed in this publication were the Hood Mysticism Scale (Hood et al., 2001), the Persisting Effects Questionnaire (Griffiths et al.”
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006, unknown): “Mysticism scale This 32-item questionnaire was developed to assess primary mystical experiences (Hood et al. 2001; Spilka et al. 2005).”
- Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (2014, methodology): “…was designed to assess primary mystical experience across the lifetime (Hood, 1975), and has been employed extensively in research, demonstrating good validity, and cross-cultural reliability (Hood et al., 2001), as well as sensitivity to the effects of psilocybin (Griffiths et al., 2006, 2011).”
- The Intratextual Fundamentalism Scale: cross-cultural application, validity evidence, and relationship with religious orientation and the Big 5 factor markers1 (2010, result): “It is noteworthy that other studies (e.g., Hood et al., 2001; Khan & Watson, 2004) used equivalent translations from English to native languages among Iranians and Pakistanis and reported higher reliabilities for scales in their studies.”
- The Varieties of Self-Transcendent Experience (2017, background): “…experiences (Cardena, Lynn, & Krippner, 2000), nondual awareness (Josipovic, 2014) near death experiences (Blackmore, 1996), mystical experiences (Hood et al., 2001; James, 1902; Newberg & d’Aquili, 2008; Wulff, 2000), and the closest to a catch-all term “religious, spiritual, and mystical…”
- Of Roots and Fruits: A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences (2017, background): “(1975), the most widely used measure for experiences involving spiritual or visceral feelings of unity (Hood et al., 2001; Lukoff & Lu, 1988).”